CHEMED CORPORATION

Analyst Reco. Chemed Corporation

Equities

CHE

US16359R1032

Market Closed - Nyse Other stock markets 01:30:02 27/04/2024 am IST			5-day change	1st Jan Change
560.4 ^USD	-2.25%		-6.66%	-4.16%

26/04	Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says	MT
25/04	Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing	22/03	MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing	22/03	MT
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept	04/03	MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating	29/02	MT
Oppenheimer Adjusts Chemed Price Target to $625 From $590, Maintains Outperform Rating	17/01	MT
RBC Raises Price Target on Chemed to $604 From $576, Keeps Outperform Rating	30/23/30	MT
RBC Cuts Price Target on Chemed to $576 From $610, Maintains Outperform Rating	31/23/31	MT
Oppenheimer Adjusts Chemed Price Target to $590 From $610, Maintains Outperform Rating	27/23/27	MT
RBC Boosts Price Target on Chemed to $610 From $587 After 'Solid Results,' Maintains Outperform Rating	01/23/01	MT
Oppenheimer Raises Chemed's Price Target to $610 From $580, Maintains Outperform Rating	28/23/28	MT
RBC Raises Price Target on Chemed to $587 From $545, Maintains Outperform Rating	27/23/27	MT
RBC Raises Price Target on Chemed to $545 From $541, Maintains Outperform Rating	03/22/03	MT
RBC Cuts Price Target on Chemed to $541 From $592, Citing Recent Industry Multiple Compression, Maintains Outperform Rating	01/22/01	MT
RBC Boosts Price Target on Chemed to $592 From $579, Maintains Outperform Rating	28/22/28	MT
RBC Cuts Price Target on Chemed to $579 From $609, Maintains Outperform Rating	04/22/04	MT
CHEMED : RBC Boosts Price Target on Chemed to $609 From $604, Citing Strong Roto-Rooter Growth, Maintains Outperform Rating	29/21/29	MT
CHEMED : RBC Boosts Price Target on Chemed to $604 From $600, Sees Guidance Raise Likely, Maintains Outperform Rating	10/21/10	MT
CHEMED : Oppenheimer Adjusts Chemed PT to $580 From $600, Maintains Outperform Rating	26/21/26	MT
CHEMED : Oppenheimer Adjusts Chemed's Price Target to $600 From $535, Maintains Outperform Rating	27/21/27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer